Unity Biotechnology, Inc. (NASDAQ:UBX) CEO Anirvan Ghosh has sold a portion of his company stock, according to recent regulatory filings. The transaction, which took place on June 25, 2024, involved ...

This press release contains forward-looking statements including statements related to UNITY’s understanding of cellular senescence and the role it plays in diseases of aging, the potential for UNITY ...

Unity Biotechnology Inc . (NASDAQ: UBX) shares have tumbled to a 52-week low, touching down at $0.66. With a current market capitalization of just $11.5 million, InvestingPro analysis suggests the ...

The event will focus on UNITY’s ongoing Phase 2b ASPIRE study evaluating foselutoclax (UBX1325) head-to-head against aflibercept in diabetic macular edema (DME). Twenty-four-week safety and efficacy ...

Unity Biotechnology, Inc. (NASDAQ: UBX) reported that its Chief Legal Officer, Alexander Hieu Nguyen, has sold a total of 78 shares of company stock. The transaction, dated June 25, 2024, was executed ...

(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release. The ...

Every investor in Unity Biotechnology, Inc. (NASDAQ:UBX) should be aware of the most powerful shareholder groups. Institutions will often hold stock in bigger companies, and we expect to see insiders ...

If you want to know who really controls Unity Biotechnology Inc (NASDAQ:UBX), then you’ll have to look at the makeup of its share registry. Institutions often own shares in more established companies, ...

If your aggregate position is larger than Tier 1, your margin requirement will not be reduced by non-guaranteed stops. Please note: we have tried to ensure that the information here is as accurate as ...